Iveco Group announces the results of the Annual General Meeting, the publication of its 2022 Sustainability Report, and the launch of an initial 55 million euro tranche of its share buyback program 14-04-2023, 17:45

Iveco Group N.V. to present its 2024 Fourth Quarter and Full Year Results on 7th February 2025 23-01-2025, 17:00

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21